Gen Digital (NASDAQ:GEN) Stock, Quote.Headers.trade-ideas

Gen Digital

Genesis Healthcare

Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.

Roblox

News

Intraday Update

Markets

Movers

Trading Ideas

ATEC

BKNG

CFLT

LMND

NCLH

PAYC

PTON

RBLX

RELY

ROOT

TTMI

TWLO

Roblox Posts Upbeat Results, Joins Paycom Software, Norwegian Cruise Line, Altria Group, Booking And Other Big Stocks Moving Higher On Thursday

Penang,,Malaysia,-,Feb,2,,2021:,Gamestop,Corp,Sign,Is

AMSWA

AONC

ASNS

ASXC

BBCP

BGXX

BMEA

BNED

BRZE

CDXC

CEA INDUSTRIES INC by CEA Industries Inc.

CEAD

CLEU

DOCU

FFIE

GERN

GRRR

LFLY

MAIA

MCRB

MITQ

MLGO

NVAX

PRST

SCNI

SIFY

SMTC

SPWR

TPHS

UPST

VERO

VLCN

YEXT

Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Wall Street ai6

Equities

Macro Economic Events

Macro Notification

Market Summary

Sector ETFs

Broad U.S. Equity ETFs

Global

Econ #s

Economics

Federal Reserve

ETFs

SPDR Dow Jones Industrial Average ETF Trust

HUBB

May labor market report: strong job gains and wage growth, reduces chances of rate cut. Interest-rate sensitive sectors underperform. Top risers: APD, URI, LLY, HUBB, ADP. Top losers: GEN, SHW, FCX, AMT.

Wall Street Reacts To Hot Jobs Report: Stocks Swing As Traders Abandon July Rate Cut Hopes

GE AEROSPACE ORD

Gen Digital Inc

Gencor Industries Inc

Genda Inc

UBS GLO GEND DIS ETF

UBS ETF GL GENDER EQ USD ETF

UBS ETF GL GENDER EQ H USD D ETF

Genetic Technologies Ltd - American Depositary Shares

Genetic Technologies Ltd

Genopets

GENFLOW BIOSCIENCES PLC by Genflow Biosciences Plc

Genflow Biosciences PLC

Gear Energy Ltd

Generation Hemp Inc

Genius Sports Ltd

GEN Restaurant Group, Inc. - Class A Common Stock

GEN Restaurant Group Inc

Genmin Ltd

Spinnaker ETF Series Genter Capital Municipal Quality Intermediate ETF

GENERATION MINING LTD by Generation Mining Limited

Generation Mining Ltd

GENESIS HEALTHCARE INC A by Genesis Healthcare, Inc.

Genesis Healthcare Inc

GENIX PHARMACEUTICALS CP by GENIX PHARMACEUTICALS CORP.

Genix Pharmaceuticals Corp

GENRE

GENERATION URANIUM INC by GENERATION URANIUM INC.

Generation Uranium Inc

Genus PLC

Spinnaker ETF Series Genter Capital Taxable Quality Intermediate ETF

G5 ENTERTAINMENT AB by G5 Entertainment AB

G5 Entertainment AB

GENEX PHARMACEUTICAL INC by Genex Pharmaceutical, Inc.

Genex Pharmaceutical Inc

AMND MILLENNIALS ETF

Principal Exchange-Traded Funds Principal Millennial Global Growth ETF

Wells Fargo maintains Gen Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) with a Overweight and raises the price target from $35 to $37.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Gen Digital, Raises Price Target to $37

WIIM

Gen Digital shares are trading higher after the company reported Q2 sales that beat analyst estimates and raised its FY25 guidance for both adjusted EPS and revenue.

Barclays analyst Saket Kalia maintains Gen Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) with a Equal-Weight and raises the price target from $28 to $30.

Barclays Maintains Equal-Weight on Gen Digital, Raises Price Target to $30

U.S. stocks were lower, with the Dow Jones index falling around 200 points on Thursday.
Shares of Roblox Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) rose sharply during Thursday&#8217;s session after the company reported better-than-expected third-quarter financial results and reported a year-over-year increase in daily <a href="https://www.benzinga.com/news/earnings/24/10/41654520/roblox-q3-earnings-bookings-jump-34-user-base-hits-89-million-raises-annual-outlook">active users and hours engaged</a>.
The video game developer reported an adjusted EPS loss of 37 cents, beating the analyst consensus loss estimate of 0.39 cents. The revenue of the American video game developer grew by 29% Y/Y to $919 million.
Roblox shares climbed 21.5% to $52.13 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Root, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) shares jumped 138% to $96.39 after the company reported better-than-expected third-quarter financial results.</li>
<li>Alphatec Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) shares climbed 40% to $7.84 after the company reported better-than-expected third-quarter revenue results and raised its FY24 revenue guidance.</li>
<li>Lemonade, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>) surged 25.8% to $23.59 after the company reported third-quarter earnings and sales above estimates and raised its FY24 guidance.</li>
<li>Paycom Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAYC#NYSE">PAYC</a>) gained 24.7% to $214.84 following better-than-expected quarterly earnings.</li>
<li>Confluent, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) rose 21.4% to $28.00 after the company reported better-than-expected quarterly financial results.</li>
<li>Remitly Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELY#NASDAQ">RELY</a>) surged 19.7% to $18.27 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates.</li>
<li>Nextracker Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>) gained 19.1% to $38.09 after the company reported better-than-expected second-quarter financial results and raised its FY25 GAAP and adjusted EPS guidance.</li>
<li>Peloton Interactive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTON#NASDAQ">PTON</a>) rose 18.6% to $7.89 after the company reported better-than-expected quarterly sales.</li>
<li>TTM Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTMI#NASDAQ">TTMI</a>) surged 16.6% to $23.01 following strong quarterly sales.</li>
<li>Twilio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) gained 16% to $81.81 after the company reported better-than-expected third-quarter financial results.</li>
<li>International Paper Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IP#NYSE">IP</a>) rose 14% to $55.91 after the company reported better-than-expected quarterly adjusted EPS results. The company announced the decision to review strategic options for its global cellulose fibers business.</li>
<li>Entergy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>) gained 11.8% to $150.32 after the company reported better-than-expected third-quarter earnings and raised FY24 EPS outlook.</li>
<li>Gen Digital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) gained 10.1% to $29.64 following strong quarterly sales.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) rose 10.1% to $130.98 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance above estimates.</li>
<li>Norwegian Cruise Line Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) gained 7.7% to $25.69 after the company reported better-than-expected quarterly financial results.</li>
<li>Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) gained 7% to $54.03 following strong earnings.</li>
<li>Booking Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) rose 6.3% to $4,745.96 after the company reported better-than-expected third-quarter financial results.</li>
</ul>
Now Read This:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41652163/jim-cramer-this-financial-stock-is-one-of-the-most-consistent-great-companies"> Jim Cramer: This Financial Stock Is &#8216;One Of The Most Consistent, Great Companies&#8217;</a></li>
</ul>

Guidance

Gen Digital Adjusts FY25 Adj. EPS From $2.17-$2.23 To $2.18-$2.23 Vs $2.21 Est.; Revenue From $3.890B-$3.930B To $3.905B-$3.930B Vs $3.913B

Gen Digital Sees Q3 Adj. EPS $0.54-$0.56; Revenue $980M-$990M

Gen Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) reported quarterly earnings of $0.54 per share which met the analyst consensus estimate. The company reported quarterly sales of $974.000 million which beat the analyst consensus estimate of $969.928 million by 0.42 percent. This is a 2.74 percent increase over sales of $948.000 million the same period last year.

Earnings

Earnings Beats

Gen Digital Q2 2025 Adj. EPS $0.54, Inline, Sales $974.000M Beat $969.928M Estimate

Barclays analyst Saket Kalia maintains Gen Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) with a Equal-Weight and raises the price target from $27 to $28.

Barclays Maintains Equal-Weight on Gen Digital, Raises Price Target to $28

RBC Capital analyst Matthew Hedberg maintains Gen Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) with a Sector Perform and raises the price target from $25 to $28.

RBC Capital Maintains Sector Perform on Gen Digital, Raises Price Target to $28

Barclays analyst Saket Kalia maintains Gen Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) with a Equal-Weight and raises the price target from $25 to $27.

Barclays Maintains Equal-Weight on Gen Digital, Raises Price Target to $27

Gen Digital shares are trading higher. The company reported Q2 financial results.

Q2 FY25 Non-GAAP Guidance
<ul>
<li>Revenue expected to be in the range of $965 to $975 million</li>
<li>EPS expected to be in the range of $0.53 to $0.55</li>
</ul>
Re-affirm Fiscal Year 2025 Non-GAAP Annual Guidance
<ul>
<li>Revenue expected to be in the range of $3,890 to $3,930 million</li>
<li>EPS expected to be in the range of $2.17 to $2.23</li>
</ul>

Gen Digital Sees Q2 EPS $0.53-$0.55 Vs $0.54 Est.; Revenue $965M-$975M Vs $968.24M Est.; Reaffirms FY EPS Guidance Of $2.17-$2.23 Vs $2.20 Est.; Revenue $3.89B-$3.93B Vs $3.91B Est.

Gen Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) reported quarterly earnings of $0.53 per share which met the analyst consensus estimate. This is a 12.77 percent increase over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $965.00 million which missed the analyst consensus estimate of $965.06 million by 0.01 percent. This is a 2.01 percent increase over sales of $946.00 million the same period last year.

Earnings Misses

Gen Digital Q1 Adj $0.53, Inline, Sales $965.00M Miss $965.06M Estimate

Shares of GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) fell sharply during Friday's session after the company released worse-than-expected first-quarter results before schedule and filed to <a href="https://www.benzinga.com/news/earnings/24/06/39224137/gamestop-releases-q1-results-ahead-of-roaring-kitty-event-files-prospectus-to-raise-capital-via-equ">sell up to 75 million shares</a>.
GameStop released its first-quarter 2024 results early Friday ahead of its scheduled June 11 date. The company reported net sales of $881.8 million, down from $1.237 billion year-over-year. The net sales total missed a consensus estimate of $995.3 million. The company reported a loss of 12 cents per share, missing the estimate of a loss of 9 cents per share, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
GameStop shares dipped 22.5% to $36.07 on Friday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Trinity Place Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPHS#NYSE">TPHS</a>) jumped 165.4% to $0.3220 after declining around 11% on Thursday.</li>
<li>Leafly Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFLY#NASDAQ">LFLY</a>) shares gained 91.6% to $3.87.</li>
<li>Venus Concept Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) shares jumped 87.5% to $1.1606 on continued upward momentum after the stock regained Nasdaq compliance.</li>
<li>Asensus Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASXC#NASDAQ">ASXC</a>) climbed 40.1% to $0.3291 after the company announced it will be acquired by KARL STORZ for $0.35 per share in cash.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) gained 29.3% to $0.7032.</li>
<li>Geron Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) shares jumped 26% to $4.90 as the company reported the FDA approval of RYTELO&#x2122; (imetelstat), a first-in-class telomerase inhibitor, for the treatment of adult patients with lower-risk MDS with transfusion-dependent anemia.</li>
<li>China Liberal Education Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLEU#NASDAQ">CLEU</a>) gained 23.4% to $2.4899.</li>
<li>American Oncology Network, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AONC#NASDAQ">AONC</a>) gained 22.6% to $2.0850. American Oncology Network recently announced the opening of Low Country Radiation in Waycross, Georgia.</li>
<li>MAIA Biotechnology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAIA#NASDAQ">MAIA</a>) rose 21.2% to $4.0249. The company unveiled compelling efficacy data from its Phase 2 THIO-101 clinical trial.</li>
<li>ChromaDex Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXC#NASDAQ">CDXC</a>) gained 19.2% to $3.41 after the company received exclusive FDA Orphan Drug Designation and Rare Pediatric Disease Designation for Nicotinamide Riboside Chloride in the treatment of Ataxia Telangiectasia.</li>
<li>SunPower Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) rose 18.8% to $4.11.</li>
<li>Oddity Tech Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) gained 18.3% to $43.49 after the company approved a share buyback and raised its Q2 guidance.</li>
<li>Universe Pharmaceuticals INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) jumped 14.3% to $2.64</li>
<li>Presto Automation Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRST#NASDAQ">PRST</a>) rose 14.1% to $0.0866 after declining 27% on Thursday.</li>
<li>Yext, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YEXT#NYSE">YEXT</a>) gained 14.7% to $5.42. Yext is said to hire investment bankers to explore strategic alternatives, including a sale, Reuters reported.</li>
<li>Argan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) jumped 11.1% to $76.78 after the company reported better-than-expected first-quarter financial results.</li>
<li>Planet Labs PBC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) gained 9.6% to $1.9950 following better-than-expected quarterly earnings.</li>
<li>Braze, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) rose 4.2% to $38.32 following better-than-expected first-quarter earnings.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Biomea Fusion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMEA#NASDAQ">BMEA</a>) shares dipped 65.6% to $3.87 after the United States Food and Drug Administration (FDA) imposed a full clinical hold on its Phase I/II trials for BMF-219, a diabetes treatment.</li>
<li>Barnes &amp; Noble Education, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNED#NYSE">BNED</a>) fell 35.3% to $0.2101 after the company announced final results of rights offering.</li>
<li>Scinai Immunotherapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) fell 31.3% to $2.7474. Scinai Immunotherapeutics regained compliance with Nasdaq minimum bid price requirement.</li>
<li>Volcon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) fell 29.3% to $9.90. Volcon recently announced a 1-for-100 reverse stock split.</li>
<li>Latam Logistic Properties, S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPA#NYSE">LPA</a>) shares fell 26.4% to $34.69 after jumping 49% on Thursday.</li>
<li>Hywin Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HYW#NYSE">HYW</a>) dipped 24.7% to $0.4670.</li>
<li>MicroAlgo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) shares fell 24.2% to $4.24. MicroAlgo recently announced that it entered into convertible note purchase agreements with certain investors.</li>
<li>Actelis Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) dipped 23% to $1.5101. Actelis announced closing of exercise of warrants for $3 million gross proceeds.</li>
<li>Semtech Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) dipped 19.6% to $30.54 after the company announced it has appointed a new President and CEO and reaffirmed Q2 2025 guidance.</li>
<li>Gorilla Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>) fell 19.3% to $4.7699 after announcing a $12 million registered direct offering.</li>
<li>Bright Green Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGXX#NASDAQ">BGXX</a>) shares fell 18.7% to $0.2851 after declining around 8% on Thursday.</li>
<li>Seres Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) declined 18.7% to $0.6916. Canaccord Genuity analyst John Newman maintained Seres Therapeutics with a Buy and lowered the price target from $15 to $10.</li>
<li>CEA Industries Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEAD#NASDAQ">CEAD</a>) dipped 18% to $6.65.</li>
<li>Oil-Dri Corporation of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ODC#NYSE">ODC</a>) fell 17.3% to $68.57 following third-quarter results.</li>
<li>mF International Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFI#NASDAQ">MFI</a>) fell 17.1% to $1.07.</li>
<li>Vail Resorts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) shares declined 13.6% to $167.50 after the company reported weaker-than-expected results for its third quarter on Thursday.</li>
<li>Samsara Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) shares dipped 13.4% to $30.17 after the company reported first-quarter earnings.</li>
<li>Moving iMage Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#NYSE">MITQ</a>) fell 10.3% to $0.6001 after declining 33% on Thursday. Moving iMage Technologies was recently awarded a multi-million dollar contract.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) declined 10.2% to $17.56.</li>
<li>Sify Technologies Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) fell 10.1% to $0.8001 as the company announced commencement of its previously announced rights offering.</li>
<li>Harmony Gold Mining Company Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMY#NYSE">HMY</a>) fell 9.2% to $8.36. Shares of precious metals companies traded lower amid a decline in gold and silver following US economic data.</li>
<li>Concrete Pumping Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBCP#NASDAQ">BBCP</a>) shares dipped 8% to $6.93 after posting weaker-than-expected second-quarter results.</li>
<li>Upstart Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) tumbled 8% to $24.75.</li>
<li>American Software, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSWA#NASDAQ">AMSWA</a>) declined 7.5% to $9.55 following quarterly results. B. Riley Securities analyst Zach Cummings maintained American Software with a Buy and lowered the price target from $16 to $14.</li>
<li>DocuSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) shares fell 7.4% to $50.57. DocuSign reported better-than-expected earnings for its first quarter and the company&#8217;s board also authorized a $1 billion increase to its existing stock repurchase program. The company said it sees second-quarter billings in the range of $715 million to $725 million.</li>
<li>Impinj, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>) fell 7.1% to $153.03.</li>
<li>Gen Digital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) declined 5.2% to $24.13 after Morgan Stanley downgraded the stock from Overweight to Equal-Weight and lowered its price target from $28 to $27.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/06/39226995/over-2m-bet-on-this-tech-stock-check-out-these-4-stocks-insiders-are-buying">Over $2M Bet On This Tech Stock? Check Out These 4 Stocks Insiders Are Buying</a>

Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session

The May labor market report delivered hotter-than-expected numbers in terms of job <a href="https://www.benzinga.com/news/large-cap/24/06/39225961/job-market-booms-in-may-payrolls-surge-more-than-expected-wages-increase">gains and wage growth.</a>
Last month, U.S. employers added 272,000 nonfarm payrolls, a sharp increase from April&#8217;s 165,000 and well above the expected 180,000.
Average hourly earnings witnessed a 4.1% year-on-year surge, up from an upwardly revised 4% in April, and above the expected 3.9%. On a monthly basis, earnings advanced at a 0.4% pace, accelerating from the previous 0.2%, and above the predicted 0.3%.
Overall, it was a hot jobs report on almost all fronts, except for a slight uptick in the unemployment rate from 3.9% to 4%.
The market interpreted these data as the final nail in the coffin for the already slim chances of a potential rate cut in July. Fed futures now indicate cumulative cuts of less than 50 basis points – less than two 25 basis point cuts – by the end of the year.
A solid and tight labor market indeed reduces the risks of a slowdown, which might have prompted the Fed to be more aggressive in cutting rates. Meanwhile, wage growth increases inflation risks, as demand from U.S. consumers is expected to remain strong.
Wall Street experienced a marginal decline following the report, with all major indices trading slightly in the red by 10:15 a.m. in New York.
<ul>
<li>The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was 0.1% lower, according to Benzinga Pro data.</li>
<li>The tech-heavy QQQ Invesco Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) also eased 0.1%.</li>
<li>Blue-chip stocks, as tracked by the SPDR Dow Jones Industrial Average ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>), inched 0.1% higher.</li>
<li>Small caps, as monitored through the iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>), fell 0.6%.</li>
</ul>
Sector-specific reactions were more bold. Interest-rate sensitive sectors such as real estate and materials underperformed, while financials and health care outperformed.
Here is an overview of the major stock movers – driven primarily by reactions to May&#8217;s jobs report, rather than earnings reports.
<h3 class="wp-block-heading">Top 5 S&amp;P 500 Gainers On Jobs Data</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Name</td>
<td>Last</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Air Products and Chemicals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>)</td>
<td>276.59</td>
<td>2.55%</td>
</tr>
<tr>
<td>United Rentals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>)</td>
<td>644.85</td>
<td>2.27%</td>
</tr>
<tr>
<td>Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>)</td>
<td>852.23</td>
<td>1.78%</td>
</tr>
<tr>
<td>Hubbell Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBB#NYSE">HUBB</a>) </td>
<td>372.44</td>
<td>1.78%</td>
</tr>
<tr>
<td>Automatic Data Processing, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADP#NYSE">ADP</a>)</td>
<td>252.35</td>
<td>1.77%</td>
</tr>
</tbody>
</table>
</figure>
<h3 class="wp-block-heading">Top 5 S&amp;P 500 Losers On Jobs Data</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Name</td>
<td>Last</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Gen Digital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>)</td>
<td>24.00</td>
<td>-5.68%</td>
</tr>
<tr>
<td>The Sherwin-Williams Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>)</td>
<td>292.32</td>
<td>-3.86%</td>
</tr>
<tr>
<td>Freeport-McMoRan Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>)</td>
<td>49.47</td>
<td>-3.48%</td>
</tr>
<tr>
<td>American Tower Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMT#NYSE">AMT</a>)</td>
<td>192.69</td>
<td>-3.41%</td>
</tr>
<tr>
<td>Newmont Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>)</td>
<td>41.18</td>
<td>-3.11%</td>
</tr>
</tbody>
</table>
</figure>
Read now: <a href="https://www.benzinga.com/markets/equities/24/06/39213777/nvidia-propels-semiconductor-industry-to-5-5-trillion-valuation-beginning-of-bigger-boom-says-an">Nvidia Propels Semiconductor Industry To $5.5 Trillion Valuation; Beginning Of Bigger Boom, Says Analyst</a>
Image generated using artificial intelligence via Midjourney.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-ratings/">analyst ratings page</a>.
<ul>
<li>JP Morgan analyst Matthew Boss downgraded the rating for Vail Resorts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) from Neutral to Underweight, while cutting the price target from $217 to $176. Vail Resorts shares gained 0.6% to close at $193.95 on Thursday. <a href="https://www.benzinga.com/quote/MTN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Hamza Fodderwala downgraded Gen Digital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) from Overweight to Equal-Weight and slashed the price target from $28 to $27. Gen Digital shares fell 0.1% to settle at $25.44 on Thursday. <a href="https://www.benzinga.com/quote/GEN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler analyst Joseph Catanzaro downgraded the rating for Halozyme Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HALO#NASDAQ">HALO</a>) from Overweight to Neutral, but raised the price target from $48 to $51. Halozyme Therapeutics shares rose 12.7% to settle at $51.44 on Thursday. See how other analysts view this stock. <a href="https://www.benzinga.com/quote/HALO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Truist Securities analyst Neal Dingmann downgraded Exxon Mobil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) from Buy to Hold and cut the price target from $146 to $124. Exxon Mobil shares rose 0.8% to close at $113.97 on Thursday. <a href="https://www.benzinga.com/quote/XOM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>William Blair analyst Tim Mulrooney downgraded the rating for Concrete Pumping Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBCP#NASDAQ">BBCP</a>) from Outperform to Market Perform. Concrete Pumping shares rose 0.7% to settle at $7.53 on Thursday. <a href="https://www.benzinga.com/quote/BBCP/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/24/06/39224737/wall-streets-most-accurate-analysts-weigh-in-on-3-risk-off-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Risk Off Stocks Delivering High-Dividend Yields</a>

Downgrades

HALO

This Exxon Mobil Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Gen Digital shares are trading lower after Morgan Stanley downgraded the stock from Overweight to Equal-Weight and lowered its price target from $28 to $27.

Morgan Stanley analyst Hamza Fodderwala downgrades Gen Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) from Overweight to Equal-Weight and lowers the price target from $28 to $27.

Morgan Stanley Downgrades Gen Digital to Equal-Weight, Lowers Price Target to $27

Argus Research analyst Joseph Bonner maintains Gen Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) with a Buy and raises the price target from $26 to $29.

Argus Research Maintains Buy on Gen Digital, Raises Price Target to $29

Peter A Feld, Director at Gen Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>), disclosed an insider sell on May 17, according to a recent SEC filing.
What Happened: According to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000849399/000119380524000671//Archives/edgar/data/849399/000119380524000671/0001193805-24-000671-index.htm">U.S. Securities and Exchange Commission</a> on Friday, Feld sold 1,092,300 shares of Gen Digital. The total transaction value is $26,846,361.
As of Friday morning, Gen Digital shares are down by 1.1%, currently priced at $25.13.
<h3>Delving into Gen Digital's Background</h3>
Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.
<h3>Gen Digital's Financial Performance</h3>
Revenue Growth: Over the 3 months period, Gen Digital showcased positive performance, achieving a revenue growth rate of 1.68% as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 80.35%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): Gen Digital's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 0.21.
</li>
</ul>
Debt Management: Gen Digital's debt-to-equity ratio is notably higher than the industry average. With a ratio of 3.92, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Evaluating Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 26.47, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 4.28 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a below-average EV/EBITDA ratio of 14.71, Gen Digital presents an opportunity for value investors. This lower valuation may attract investors seeking undervalued opportunities.
</li>
</ul>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Breaking Down the Significance of Transaction Codes</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000849399">Check Out The Full List Of Gen Digital's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Gen Digital Insider Trades Send A Signal

Gen Digital: Improving Cash Flows Support Deleveraging

Analysts have been eager to weigh in on the Technology sector with new ratings on TELUS International (CDA) (TIXT – Research Report), Gen Digital (...

Analysts Have Conflicting Sentiments on These Technology Companies: TELUS International (CDA) (TIXT), Gen Digital (GEN) and Pegasystems (PEGA)

Mega Tech Will Shape The Earnings Season And U.S. Markets When They Report This Week

Gen Digital Non-GAAP EPS of $0.54 in-line, revenue of $974M beats by $2.7M

Gen Digital Inc. 2025 Q2 - Results - Earnings Call Presentation

Gen Digital Inc. (GEN) Q2 2025 Earnings Call Transcript

Gen Digital Inc. ( ($GEN) ) has realeased its Q2 earnings. Here is a breakdown of the information Gen Digital Inc. presented to its investors. Gen ...

Gen Digital Inc. Reports Strong Q2 FY25 Results

Hamza Fodderwala, an analyst from Morgan Stanley, maintained the Hold rating on Gen Digital (GEN – Research Report). The associated price target is...

Gen Digital: Positive Revenue Growth Amidst Margin and Capital Strategy Concerns – Hold Rating Justified

Wells Fargo raised the firm's price target on Gen Digital (GEN) to $37 from $35 and keeps an Overweight rating on the shares. The firm expects shar...

Gen Digital price target raised to $37 from $35 at Wells Fargo

Notable gainers among liquid option names this morning include Paycom (PAYC) $213.59 +41.34, International Paper (IP) $55.54 +6.51, Entergy (ETR) $...

Early notable gainers among liquid option names on October 31st

AAPL

AMZN

CHTR

CMCSA

GDDY

GOOG

GOOGL

JNPR

MSFT

NVDA

OTIS

PEGA

TIXT

TROW

TSLA

Press Releases

Parents Cautiously Optimistic on AI in Schools: Content Safety and Data Privacy Among Top Worries

Legal

GAINEY McKENNA & EGLESTON Announces Proposed Class Action Settlement on Behalf of Purchasers of Symantec Corporation n/k/a Gen Digital Inc. Common Stock in the Symantec Corporation Employee Stock Purchase Plan - GEN

Fintech

Multi-million-dollar Deepfake Campaigns Blocked by Gen

AARP Services Announces New Enhanced Offerings for AARP Members This Fall

Insurance

Norton Benefit Solutions Expands Global Offering

Opinion

Ransomware Costs Surge as Quantum Computing Risks Loom: How Data Security Stocks Are Responding

Gen to Announce Fiscal 2025 Second Quarter Results on October 30, 2024

Election Scams on the Rise: Over Half of Americans Targeted with Election Scams

Don't Let Scammers Steal Your Holiday Cheer: New Norton Report Reveals Nearly Half of U.S. Consumers Were Targeted by a Scam While Online Shopping

Dividends

Gen Reports Second Quarter Fiscal Year 2025 Results

CSE:SCPE

Comments

Gen Digital

Gen Digital (GEN) Forecast

Gen Digital (NASDAQ:GEN) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga